{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:20:07Z","timestamp":1787847607943,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pertussis is a vaccine-preventable respiratory infection and seroepidemiology of the infection could be a marker of the pertussis immunity in a population. In many countries, despite vaccination coverage, high prevalence of pertussis has been observed. The present study aimed to evaluate the immunoglobulin G (IgG) antibody against pertussis and the role of demographic and anthropometric variables on the immunity rate in the Iranian pediatric population to evaluate the impact of existing immunization program in order to envisage future vaccination strategies to prevent infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      In a cross-sectional multi-centric study, 1593 samples of the students aged 7\u201318 years, who had been enrolled in a national survey (Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable disease-V), were randomly selected and tested for IgG antibody against\n                      <jats:italic toggle=\"yes\">Bordetella pertussis<\/jats:italic>\n                      (BP) by enzyme-linked immunosorbent assay. The age, gender, education, residency, geographical region, and body mass index (BMI) were extracted from the questionnaires of the COSPIAN-Survey. Multiple logistic regression models were used to assess the associations between the variables with the IgG antibody against BP. Data were presented by odds ratio (OR), 95% confidence interval (95% CI) and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      values (P): (OR [95% CI]; P).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Subjects were consisted of 774 boys and 750 girls, with a mean (standard deviation) age of 12.39 (3.03) years. Overall, BP seroprevalence was 59.8%. There were higher BMI values in seronegative ones versus seropositive (18.62 \u00b1 4.07 vs. 18.15 \u00b1 3.94,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.041, 95% CI = 0.23 [0.02\u20130.92]). However, the categorized BMI for age was not significantly associated with IgG levels (0.27 [0.25\u20130.29]; 0.27). BP seroprevalence was not significantly different between geographical regions (0.06 [0.05\u20130.07]; 0.06), genders (1.17 [0.93\u20131.47]; 0.18), area of residence (1.07 [0.82\u20131.4]; 0.61), and educational levels (0.94 [0.75\u20131.19]; 0.62).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>IgG antibody against pertussis was not detected in nearly 40% of the subjects who had history of vaccination against pertussis. It is recommended to monitor the incidence of pertussis in high-risk populations closely and administer a booster dose of acellular pertussis vaccine in adolescents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jrms.jrms_636_19","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T11:16:47Z","timestamp":1617275807000},"page":"21","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Seroprevalence of Bordetella pertussis among a nationally representative sample of Iranian pediatric population"],"prefix":"10.4103","volume":"26","author":[{"given":"Zary","family":"Nokhodian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz","family":"Ataei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohsen","family":"Zahraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Gouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervin Ghaffari","family":"Hoseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Yaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Mansourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Esmaeil","family":"Motlagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Heshmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Kelishadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20240830","doi-asserted-by":"crossref","first-page":"e5514","DOI":"10.5812\/ijp.5514","article-title":"Old disease and new challenges: Major obstacles of current strategies in the prevention of pertussis","volume":"26","author":"Sedighi","year":"2016","journal-title":"Iran J Pediatr"},{"key":"R2-21-20240830","first-page":"68","article-title":"Pertussis: New preventive strategies for an old disease","volume":"29","author":"Di Mattia","year":"2019","journal-title":"Paediatr Respir Rev"},{"key":"R3-21-20240830","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1586\/14760584.2014.935765","article-title":"Adult pertussis in the pre- and post-vaccine eras: Lifelong vaccine-induced immunity?","volume":"13","author":"Cherry","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"R4-21-20240830","first-page":"433","article-title":"Pertussis vaccines: WHO position paper August 2015.Weekly Epidemiological Record=Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire","volume":"90","author":"World Health","year":"2015","journal-title":"World Health Organ"},{"key":"R5-21-20240830","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/cid\/civ472","article-title":"Risk factors associated with infant deaths from pertussis: A case-control study","volume":"61","author":"Winter","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R6-21-20240830","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.meegid.2016.02.032","article-title":"Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence","volume":"40","author":"Sealey","year":"2016","journal-title":"Infect Genet Evol"},{"key":"R7-21-20240830","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1586\/14760584.2015.964212","article-title":"Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: Influence, impact and implications","volume":"14","author":"Dub\u00e9","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"R8-21-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftv050","article-title":"Seroprevalence studies of pertussis: What have we learned from different immunized populations","volume":"73","author":"Barkoff","year":"2015","journal-title":"Pathog Dis"},{"key":"R9-21-20240830","first-page":"260","article-title":"Serologic evidence of pertussis infection in vaccinated Iranian children","volume":"37","author":"Dashti","year":"2012","journal-title":"Iran J Med Sci"},{"key":"R10-21-20240830","doi-asserted-by":"crossref","first-page":"623","DOI":"10.26719\/2014.20.10.623","article-title":"Seroprevalence of pertussis antibodies in 6-17-year-old students in Ahvaz, south-west Islamic Republic of Iran","volume":"20","author":"Shamsizadeh","year":"2014","journal-title":"East Mediterr Health J"},{"key":"R11-21-20240830","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cid\/cir836","article-title":"The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization","volume":"54","author":"Skowronski","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R12-21-20240830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/INF.0000000000000921","article-title":"Trends in pertussis diagnostic testing in the United States, 1990 to 2012","volume":"35","author":"Faulkner","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R13-21-20240830","first-page":"171","article-title":"Seroprevalence of IgG antibodies against bordetella pertussis in different age groups in Tehran, Iran","volume":"7","author":"Eslamifar","year":"2012","journal-title":"Iran J Pathol"},{"key":"R14-21-20240830","first-page":"250","article-title":"Seroprevalence of antibodies to diphtheria, tetanus and pertussis among healthy adolescents and adults in Iran","volume":"72","author":"Pourakbari","year":"2013","journal-title":"Roum Arch Microbiol Immunol"},{"key":"R15-21-20240830","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2008-7802.198915","article-title":"Methodology and early findings of the fifth survey of childhood and adolescence surveillance and prevention of adult noncommunicable disease: The CASPIAN-V study","volume":"8","author":"Motlagh","year":"2017","journal-title":"Int J Prev Med"},{"key":"R16-21-20240830","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1478-7954-9-55","article-title":"National and subnational mortality effects of metabolic risk factors and smoking in Iran: A comparative risk assessment","volume":"9","author":"Farzadfar","year":"2011","journal-title":"Popul Health Metr"},{"key":"R17-21-20240830","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s13312-011-0094-x","article-title":"Growth pattern of schoolchildren in Sagamu, Nigeria using the CDC standards and 2007 WHO standards","volume":"48","author":"Fetuga","year":"2011","journal-title":"Indian Pediatr"},{"key":"R18-21-20240830","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1097\/INF.0000000000001711","article-title":"A National Seroepidemiologic Survey of pertussis among school children in Taiwan","volume":"36","author":"Lu","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R19-21-20240830","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.vaccine.2018.01.048","article-title":"School-age children and adolescents suspected of having been to be infected with pertussis in Japan","volume":"36","author":"Yasui","year":"2018","journal-title":"Vaccine"},{"key":"R20-21-20240830","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1016\/j.vaccine.2014.07.066","article-title":"Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia","volume":"32","author":"J\u03bcgi","year":"2014","journal-title":"Vaccine"},{"key":"R21-21-20240830","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-21-20240830","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1016\/j.vaccine.2012.03.059","article-title":"Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: Waning pertussis immunity in a highly immunized population and the need for adolescent booster doses","volume":"30","author":"Lai","year":"2012","journal-title":"Vaccine"},{"key":"R23-21-20240830","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1017\/S0950268813001313","article-title":"Seroprevalence of Bordetella pertussis in the Mexican population: A cross-sectional study","volume":"142","author":"Conde-Glez","year":"2014","journal-title":"Epidemiol Infect"},{"key":"R24-21-20240830","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12098-011-0593-8","article-title":"Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: The role of subclinical pertussis infection","volume":"79","author":"Saffar","year":"2012","journal-title":"Indian J Pediatr"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.JRMS_636_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:23:52Z","timestamp":1787844232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.JRMS_636_19"}},"subtitle":["The childhood and adolescence surveillance and prevention of adult noncommunicable disease-V study"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jrms.jrms_636_19","relation":{},"ISSN":["1735-1995"],"issn-type":[{"value":"1735-1995","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}